High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 543-550

  Bauer, Alison K ^a   Dwyer Nield, Lori D ^a   Malkinson, Alvin M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; URETHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; BRONCHUS MUSCLE; CANCER GROWTH; CLARA CELL; CONTROLLED STUDY; CYSTADENOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034008165     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.543     Document Type: Article

References (49)

1. Landis, S.H., Murray, T., Bolden, S. and Wingo, P.A. (1999) Cancer statistics, 1999. CA Cancer J. Clin., 49, 8-31.
2. Gazdar, A.F. and Linnoila, R.I. (1988). The pathology of lung cancer-changing concepts and newer diagnostic techniques. Semin. Oncol., 15, 215-225.
3. Moore, D.F.Jr and Lee, J.S. (1996) Staging and prognostic factors: non-small cell lung cancer. In Pass, H.I., Mitchell, J.B., Johnson, D.H. and Turrisi, A.T. (eds) Lung Cancer: Principles und Practice. Lippincott-Raven, Philadelphia, PA, pp. 481-494.
4. Thun, M.J. (1994) Aspirin, NSAIDs and digestive tract cancers. Cancer Metastasis Rev., 13, 269-277.
5. Schreinemachers, D.M. and Everson, R.B. (1994) Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology, 5, 138-146.
6. Wu, K.K. (1996) Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles. J. Lab. Clin. Med., 128, 242-245.
7. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, B. and DuBois, R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
8. Zimmermann, K.C., Sarbia, M., Weber, A., Borchard, F., Gabbert, H.E. and Schror, K. (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res., 59, 198-204.
9. Chan, G. Boyle, J.O., Yang, E.K., Zhang, F., Sacks, P.G., Shah, J.P., Edelstein, D., Soslow, R.A., Koki, A.T., Woerner, B.M., Masferrer, J.L. and Dannenberg, A.J. (1999) Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59, 991-994.
10. Huang, M., Stolina, M. Sharma, S., Mao, J.T., Zhu, L., Miller, P.W., Wollman, J., Herschman, H. and Dubinett, S.M. (1998) Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin10 and down-regulation of interleukin12 production. Cancer Res., 58, 1208-1216.
11. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K.-I., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T. and Takahashi, T. (1998) Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58, 3761-3764.
12. Wolff, H., Saukkonen, K., Anttila, S., Karjallainen, A., Vainio, H. and Ristimaki, A. (1998) Expression of cycloonygenase-2 in human lung carcinoma. Cancer Res., 58, 4997-5001.
13. Vane, J.R. Bakhle, Y.S. and Botting, R.M. (1998) Cyclooxygenase 1 and 2. Annu. Rev. Pharmacol. Toxicol, 38, 97-120.
14. Wallace, J.L. (1999) Selective COX-2 inhibitors: is the water becoming muddy? Trends Pharmacol., 20, 4-6.
15. Malkinson, A.M. (1992) Primary lung tumors in mice: an experimentally manipulate model of human adenocarcinoma. Cancer Res., 52, 2670s-2676s.
16. Malkinson, A.M. (1998) Molecular comparisons of human and mouse pulmonary adenocarcinomas. Exp. Lung Res., 24, 541-555.
17. Malkinson, A.M. and Beer, D.S. (1983) Major effect of susceptibility to urethane-induced pulmonary adenoma by a single gene in BALB/cBy mice. J. Natl Cancer Inst., 70, 931-936.
18. Horio, Y., Chen, A., Rice, R. Roth, J.A., Malkinson, A.M. and Schrump, D.S. (1996) Ki-ras and p53 mutations are early events and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol. Carcinog., 17, 217-223.
19. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein determination with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
20. Malkinson, A.M., Miley, F.B., Chichester, C.H. and Plopper, C.G. (1993) Isolation of nonciliated bronchiolar (Clara) epithelial cells from mouse lung. Methods Toxicol., 1A, 123-133.
21. Walker, S.R., Hale, S., Malkinson, A.M. and Mason, R.J. (1989) Properties of isolated nonciliated bronchiolar cells from the lung. Exp. Lung Res., 15, 553-573.
22. Kotz, S. and Johnson, N.L. (1982) Encyclopedia of Statistical Sciences. John Wiley & Sons, New York, NY, Vol. 1, pp. 378-379.
23. Sorokin, S.P. (1983) The respiratory system. In Weiss, L. (ed.) Histology, Cell and Tissue Biology, 5th Edn. Elsevier, Amsterdam, The Netherlands, pp. 788-868.
24. Kauffman, S.L., Alexander, L. and Sass, L. (1979) Histologic and ultrastructural features of the Clara cell adenoma of the mouse lung. Lab. Invest., 40, 708-716.
25. Thaete, L.G. and Malkinson, A.M. (1991) Cells of origin of primary pulmonary neoplasms in mice: morphologic and histochemical studies. Exp. Lung Res., 17, 219-228.
26. Thaete, L.G., Gunning, W.T., Stoner, G.D. and Malkinson, A.M. (1987) Cellular derivation of lung tumors in sensitive and resistant strains of mice: results at 28 and 56 weeks after urethane treatment. J. Natl Cancer Inst., 78, 743-749.
27. Hwang, D., Scollard, D., Byrne, J. and Levine, E. (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Natl Cancer Inst., 90, 455-460.
28. Elgert, K.D., Alleva, D.G. and Mullins, D.W. (1998) Tumor-induced immune dysfunction: the macrophage connection. J. Leukocyte Biol., 64, 275-290.
29. Grady, H.G. and Stewart, H.L. (1940) Histogenesis of induced pulmonary tumors in strain A mice. Am. J. Pathol., 16, 417-432.
30. Rehm, S., Ward, J.M. Have-Opbroek, A.A.W., Anderson, L.M., Singh, G., Katyal, S.L. and Rice, J.M. (1988) Evidence of alveolar type II cell origin by comparative light microscope, ultrastructural and immunohistochemical studies. Cancer Res., 48, 148-160.
31. Forkert, P.G., Parkinson, A., Thaete, L.G. and Malkinson, A.M. (1992) Resistance of murine lung tumors to xenobiotic-induced cytotoxicity. Cancer Res., 52, 6797-6803.
32. Bennett, A., Carroll, M.A., Stamford, I.F., Whimster, W.F. and Williams, F. (1982) Prostaglandins and human lung cancer. Br. J. Cancer, 46, 888-892.
33. Hubbard, W.C., Alley, M.C., Gray, G.N., Green, K.C., McLemore, J.L. and Boyd, M.R. (1989) Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors. Cancer Res., 49, 826-832.
34. Jalbert, G. and Castonguay, A. (1992) Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett., 66, 21-28.
35. Duperron, C. and Castonguay, A. (1997) Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis, 18, 1001-1006.
36. Droms, K.A., Fernandez, C.A., Thaete, L.G. and Malkinson, A.M. (1988) Effects of adrenalectomy and corticosterone administration on mouse lung tumor susceptibility and histogenesis. J. Natl Cancer Inst., 80, 365-369.
37. Wattenberg, L.W., Wiedmann, T.S., Estensen, R.D., Zimmerman, C.L., Steele, V.E. and Kelloff, G.J. (1997) Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res., 57, 5489-5492.
38. Marnett, L.J. (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52, 5575-5589.
39. Tsujii, M. and Dubois, R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase. Cell. 83, 493-501.
40. Tsujii, M. Kawano, S., Tsuji, S., Sawaoka, H., Hori, M. and DuBois, R.N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716.
41. Heasley, L.E., Thaler, S., Nicks, M., Price, B., Skoreski, K. and Nemenoff, R.A. (1997) Induction of cytoplasmic phospholipase A2 by oncogenic ras in human non-small cell lung cancer. J. Biol. Chem., 272, 14501-14504.
42. Linnoila, I. (1998) Topography of preneoplasia: morphology and markers. In Kane, M.A. and Bunn, P.A. (eds) Biology of Lung Cancer. Marcel Dekker, New York, NY, pp. 503-527.
43. Hida, T., Leyton, J., Makheja, A.N., Ben-av, P., Hla, T., Martinez, A., Mulshine, J., Malkani, S., Chung, P. and Moody, T.W. (1998) Non-small lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. Anticancer Res., 18, 775-782.
44. El-Bayoumy, K., Iatropoulos, M., Amin, S., Hoffman, D. and Wynder, E.L. (1999) Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: the impact of a high fat diet. Cancer Res., 59, 1400-1403.
45. Narko, K., Ristimiki, A., MacPhee, M. Smith, E., Haudenschild, C.C. and Hla, T. (1997) Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase 1 overexpression. J. Biol. Chem., 272, 21455-21460.
46. Ermert, L., Ermert, M., Goppelt-Struebe, M., Walmrath, D., Grimminger, F., Steudel, W., Ghofrani, H.A., Homberger, C., Duncker, H. and Seeger, W. (1998) Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am. J. Respir. Cell Mol. Biol., 18, 479-488.
47. Mason, R.J., Kalina, M., Nielsen, L.D., Malkinson, A.M. and Shannon, J.M. (2000) SP-C expression in urethane induced murine pulmonary tumors. Am. J. Pathol., 156, 175-182.
48. Adamson, I.Y.R. and Bowden, D.H. (1979) The type 2 cell as progenitor of alveolar epithelial regeneration: a cytodynamie study in mice after exposure to oxygen. Lab. Invest., 30, 35-42.
49. Devereux, T.R., Domin, B.A. and Philpot, R.M. (1993) Xenobiotic metabolism by isolated pulmonary bronchiolar and alveolar cells. In Gram, T.E. (ed.) Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells. Pergamon Press, Tarrytown, NY, pp. 25-40.